(1 - 3 of 3)
de Vries, J.J.C. (author), van Zwet, E.W. (author), Dekker, F.W. (author), Kroes, A.C.M. (author), Verkerk, P.H. (author), Vossen, A.C.T.M. (author)
Because maternal seropositivity for CMV is associated with substantial protection against congenital CMV infection, prevention measures have focused mainly on seronegative pregnant women for decades. However, population-wide insight in the contribution of nonprimary infection (reactivation and/or re-infection with a different strain) on the most...
article 2013
de Vries, J.C. (author), Korver, A.M.H. (author), Verkerk, P.H. (author), Rusman, L. (author), Claas, E.C.J. (author), Gerard, L.J. (author), Kroes, A.C.M. (author), Vossen, A.C.T.M. (author)
Congenital cytomegalovirus (CMV) infection is the most common congenital viral infection worldwide. The sequela encountered most frequently is hearing impairment, affecting approximately one out of five infants congenitally infected. Data on the birth prevalence and risk factors of congenital CMV infection in the Netherlands are scarce. The aim...
article 2011
van Spronsen, F.J. (author), Rijn, M. (author), Dorgelo, B. (author), Hoeksma, M. (author), Bosch, A.M. (author), Mulder, M.F. (author), de Klerk, J.B.C. (author), de Koning, T. (author), Rubio-Gozalbo, M.E. (author), de Vries, M. (author), Verkerk, P.H. (author)
Background: The clinical severity of phenylalanine hydroxylase deficiency is usually defined by either pre-treatment phenylalanine (Phe) concentration or Phe tolerance at 5 years of age. So far, little is known about the course of Phe tolerance or the ability of both pre-treatment Phe and Phe tolerance at early age to predict Phe tolerance at...
article 2009